Clinical applications of biomarkers in atrial fibrillation
KW Chang, JC Hsu, A Toomu, S Fox… - The American journal of …, 2017 - Elsevier
While biomarkers have greatly impacted the diagnosis and management of myocardial
infarction and heart failure, the use of biomarkers has been slow to permeate management …
infarction and heart failure, the use of biomarkers has been slow to permeate management …
Biomarkers of atrial fibrillation: Which one is a true marker?
P Ardhianto, Y Yuniadi - Cardiology research and practice, 2019 - Wiley Online Library
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmias and associated with
the risk of stroke and death. Continuous development of the diagnostic tool and prognostic …
the risk of stroke and death. Continuous development of the diagnostic tool and prognostic …
The predictive value of cardiac biomarkers in prognosis and risk stratification of patients with atrial fibrillation
JJ Brugts, S Akin, AM Helming, S Loonstra… - Current opinion in …, 2011 - journals.lww.com
New biomarkers may help to understand the mechanisms of subclinical atrial fibrillation and
signal the likelihood of disease progression. Such biomarkers, though subject to further …
signal the likelihood of disease progression. Such biomarkers, though subject to further …
Biomarkers in atrial fibrillation: a clinical review
Z Hijazi, J Oldgren, A Siegbahn… - European heart …, 2013 - academic.oup.com
Assessment of atrial fibrillation (AF)-associated stroke risk is at present mainly based on
clinical risk scores such as CHADS2 and CHA2DS2-VASc, although these scores provide …
clinical risk scores such as CHADS2 and CHA2DS2-VASc, although these scores provide …
The emerging role of biomarkers in atrial fibrillation
Improved diagnostic techniques have identified various biomarkers that might play an
important role in prediction of atrial fibrillation (AF) and related outcomes (cardio-and …
important role in prediction of atrial fibrillation (AF) and related outcomes (cardio-and …
Application of biomarkers for risk stratification in patients with atrial fibrillation
Z Hijazi, J Oldgren, A Siegbahn, L Wallentin - Clinical chemistry, 2017 - academic.oup.com
BACKGROUND Atrial fibrillation is the most common sustained arrhythmia and an important
contributor to cardiovascular morbidity and mortality. Several strategies have been proposed …
contributor to cardiovascular morbidity and mortality. Several strategies have been proposed …
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation …
Z Hijazi, J Oldgren, U Andersson, SJ Connolly… - Circulation, 2012 - Am Heart Assoc
Background—Cardiac biomarkers are strong predictors of adverse outcomes in several
patient populations. We evaluated the prevalence of elevated troponin I and N-terminal pro …
patient populations. We evaluated the prevalence of elevated troponin I and N-terminal pro …
Cardiovascular biomarker score and clinical outcomes in patients with atrial fibrillation: a subanalysis of the ENGAGE AF-TIMI 48 randomized clinical trial
CT Ruff, RP Giugliano, E Braunwald… - JAMA …, 2016 - jamanetwork.com
Importance Treatment decisions in atrial fibrillation (AF) are based on clinical assessment of
risk. The CHA 2 DS 2-VASc (cardiac failure or dysfunction, hypertension, age 65-74 [1 point] …
risk. The CHA 2 DS 2-VASc (cardiac failure or dysfunction, hypertension, age 65-74 [1 point] …
Use of biomarkers to predict specific causes of death in patients with Atrial fibrillation: Insights from the Aristotle Trial
A Sharma, Z Hijazi, U Andersson, SM Al-Khatib… - Circulation, 2018 - Am Heart Assoc
Background: Atrial fibrillation is associated with an increased risk of death. High-sensitivity
troponin T, growth differentiation factor-15, NT-proBNP (N-terminal pro-B-type natriuretic …
troponin T, growth differentiation factor-15, NT-proBNP (N-terminal pro-B-type natriuretic …
Biomarkers in atrial fibrillation: an overview
JA Vilchez, V Roldan… - … journal of clinical …, 2014 - Wiley Online Library
Atrial fibrillation (AF) confers a raised risk of stroke and death, and this risk of adverse events
is increased by the coexistence of other cardiovascular risk factors. The pathophysiology of …
is increased by the coexistence of other cardiovascular risk factors. The pathophysiology of …
相关搜索
- atrial fibrillation cardiac biomarkers
- atrial fibrillation death in patients
- atrial fibrillation risk stratification
- atrial fibrillation clinical applications
- atrial fibrillation true marker
- application of biomarkers risk stratification
- atrial fibrillation randomized evaluation
- atrial fibrillation anticoagulation therapy
- biomarker score clinical outcomes
- atrial fibrillation predictive value
- atrial fibrillation application of biomarkers
- atrial fibrillation use of biomarkers
- atrial fibrillation biomarker score
- atrial fibrillation clinical outcomes
- atrial fibrillation stroke and death
- atrial fibrillation increased risk